Based on the measurements of operating efficiency obtained from STERIS Plc's historical financial statements, STERIS plc is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in April. At present, STERIS Plc's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 577.3 M, whereas Cash And Short Term Investments are forecasted to decline to about 126.3 M. Key indicators impacting STERIS Plc's financial strength include:
The essential information of the day-to-day investment outlook for STERIS Plc includes many different criteria found on its balance sheet. An individual investor should monitor STERIS Plc's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in STERIS Plc.
Please note, the presentation of STERIS Plc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, STERIS Plc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of STERIS Plc's management manipulating its earnings.
STERIS Plc Stock Summary
STERIS Plc competes with Orthofix Medical, Glaukos Corp, Bruker, CONMED, and Anika Therapeutics. STERIS plc provides infection prevention and other procedural products and services worldwide. The company was founded in 1985 and is based in Dublin, Ireland. Steris Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 16000 people.
Comparative valuation techniques use various fundamental indicators to help in determining STERIS Plc's current stock value. Our valuation model uses many indicators to compare STERIS Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across STERIS Plc competition to find correlations between indicators driving STERIS Plc's intrinsic value. More Info.
STERIS plc is rated fourth in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about 0.58 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for STERIS plc is roughly 1.72 . At present, STERIS Plc's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value STERIS Plc by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
STERIS plc Systematic Risk
STERIS Plc's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. STERIS Plc volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on STERIS plc correlated with the market. If Beta is less than 0 STERIS Plc generally moves in the opposite direction as compared to the market. If STERIS Plc Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one STERIS plc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of STERIS Plc is generally in the same direction as the market. If Beta > 1 STERIS Plc moves generally in the same direction as, but more than the movement of the benchmark.
STERIS Plc Thematic Clasifications
STERIS plc is part of Obamacare Repeal investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal
This theme covers Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. Get More Thematic Ideas
Today, most investors in STERIS Plc Stock are looking for potential investment opportunities by analyzing not only static indicators but also various STERIS Plc's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of STERIS Plc growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.27
At present, STERIS Plc's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
STERIS Plc March 19, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of STERIS Plc help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of STERIS plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of STERIS plc based on widely used predictive technical indicators. In general, we focus on analyzing STERIS Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build STERIS Plc's daily price indicators and compare them against related drivers.
When running STERIS Plc's price analysis, check to measure STERIS Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STERIS Plc is operating at the current time. Most of STERIS Plc's value examination focuses on studying past and present price action to predict the probability of STERIS Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STERIS Plc's price. Additionally, you may evaluate how the addition of STERIS Plc to your portfolios can decrease your overall portfolio volatility.
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.